Pittenger & Anderson »

Halozyme Therapeutics shares owned by Pittenger & Anderson

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pittenger & Anderson from 13F filings

Historical chart of Pittenger & Anderson investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pittenger & Anderson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pittenger & Anderson

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4k 77 57.25

More positions owned by Pittenger & Anderson

Fiserv (FI)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Apple (AAPL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Amazon (AMZN)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Cintas Corporation (CTAS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Pittenger & Anderson

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Goldman Sachs Group
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics